Entrada Therapeutics Appoints Dr Bernhardt Zeiher to its Board of Directors Entrada Therapeutics NASDAQTRDA

BOSTON, April 04, 2023 (GLOBE NEWSWIRE) — Entrada Therapeutics, Inc. TRDA, a biopharmaceutical company aiming to transform the lives of patients by establishing intracellular Endosomal Escape Vehicle (EEV™)-therapeutics as a new class of medicines, today announced the appointment of Dr. Bernhardt “Bernie” Zeiher to its Board of Directors, effective immediately. Dr. Zeiher served most recently as the Chief Medical Officer at Astellas Pharma. “Bernie is a dynamic life sciences leader and we look forward to having him join our Board of Directors,” said Dipal Doshi, President and Chief Executive Officer of Entrada. “As the former Chief Medical Officer and President…